The Impact of Retropubic Lidocaine vs Saline on Postoperative Urinary Retention Following Midurethral Sling
Stress Urinary Incontinence
About this trial
This is an interventional prevention trial for Stress Urinary Incontinence
Eligibility Criteria
Inclusion Criteria:
- Age 18 years or older
- English speaking
- Competent to give consent
Exclusion Criteria:
- A known intolerance or allergic reaction to local anesthetics
- Planned spinal anesthesia for the procedure
- Planned concomitant prolapse repair other than anterior repair
- Preoperative voiding dysfunction as evidenced by a postvoid residual (PVR) of 150 mL or greater.
Sites / Locations
- West Penn HospitalRecruiting
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
0.5% lidocaine with epinephrine
Normal saline with epinephrine
On the day of surgery, the operating room pharmacist will prepare 20 cc of either study drug (0.5% lidocaine with epinephrine 1:200,000) or normal saline with epinephrine 1:200,000) in identical appearing 20cc syringes to be injected retropubically. Our group's routine clinical practice is to inject 20cc of 0.5% lidocaine with epinephrine 1:200,000 retropubically along the path of the midurethral sling trocars. Suburethral injection of local anesthestic will be performed at surgeon discretion. Surgical teams, anesthesia teams and patients will be blinded to allocation assignment. The investigational drug pharmacist will maintain the randomization sequence.
On the day of surgery, the operating room pharmacist will prepare 20 cc of either study drug (0.5% lidocaine with epinephrine 1:200,000) or normal saline with epinephrine 1:200,000) in identical appearing 20cc syringes to be injected retropubically. Our group's routine clinical practice is to inject 20cc of 0.5% lidocaine with epinephrine 1:200,000 retropubically along the path of the midurethral sling trocars. Suburethral injection of local anesthestic will be performed at surgeon discretion. Surgical teams, anesthesia teams and patients will be blinded to allocation assignment. The investigational drug pharmacist will maintain the randomization sequence.